影响韩国血造干细胞移植患者创伤后生长的因素:描述性调查研究
1Department of Clinical Research Design & Evaluation, Samsung Advanced Institute for Health Sciences & Technology (SAIHST), Sungkyunkwan University, Seoul, South Korea.
BMC cancer
|November 8, 2025
概括
血造干细胞移植 (HSCT) 接受者可以经历创伤后生长 (PTG). 关键的PTG预测因素包括婚姻状况,积极的变化,反,移植类型和社会支持.
科学领域:
- 血液学 血液学 血液学
- 心理学 心理学 心理学
- 在瘤学瘤学.
背景情况:
- 造血干细胞移植 (HSCT) 经常与负面结果有关.
- 创伤后成长 (PTG) 代表创伤后的积极心理变化.
- 有限的研究存在于PTG在HSCT接受者.
研究的目的:
- 调查PTG作为HSCT接受者的首要结局.
- 在这个人群中确定PTG的心理社会和临床预测因素.
主要方法:
- 在移植后一年内注册成年HSCT接受者.
- 数据收集包括结构化问卷和电子病历.
- 统计分析包括描述性统计,t测试,ANOVA,相关性和多重回归.
主要成果:
- 包括106名患者,平均PTG得分为73.75.5的患者.
- 自主移植接受者报告的PTG比兄弟姐妹或非相关的捐赠者接受者高.
- 重要的PTG预测因素包括婚姻状况,积极变化,反,移植类型和社会支持,解释了53%的差异.
结论:
- 需要量身定制的干预措施来解决影响PTG在HSCT接受者的因素.
- 瘤护士在评估心理社会需求和支持康复方面发挥着至关重要的作用.
- 个性化,基于证据的护理策略可以促进心理健康和PTG.
相关概念视频
Role of Hematopoietic Growth Factors
3.1K
Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
Thrombopoietin (TPO), mainly released by the liver,...
3.1K
Bone Marrow Sampling and Transplants
846
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
846
Stem Cell Therapy for Tissue Regeneration
4.6K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.6K
Regulation of Hematopoietic Stem Cells
3.9K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.9K


